ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SIBN vs BBNX // EV/EBITDA & P/E VALUATION

SI-BONE Inc. (NASDAQ) VS. Beta Bionics Inc. (NASDAQ) • 15-METRIC TALLY: SIBN 8 — BBNX 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIBN VS. BBNX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SIBN BBNX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 79.60% 55.40% +24.20 SIBN /gross-margins <GO>
Return on Invested Capital (ROIC) -10.30% -22.10% +11.80 SIBN /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -0.90% -5.88% +4.98 SIBN /fcf-yield <GO>
Operating Margin -11.10% -60.00% +48.90 SIBN /operating-margins <GO>
Net Profit Margin -9.40% -60.00% +50.60 SIBN /net-margins <GO>
Revenue Growth (YoY) 20.20% 53.90% -33.70 BBNX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.73 12.82 -4.09 BBNX /balance-sheet <GO>
Piotroski F-Score Quality 6/9 4/9 +2.00 SIBN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 58.6 41.5 +17.14 SIBN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.00B $955.8M $48.6M SIBN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SIBN REV BBNX REV SIBN GROSS % BBNX GROSS % SIBN FCF BBNX FCF
FY 2025 $200.9M $100.3M 79.6% 55.4% -$9.1M -$56.2M
FY 2024 $167.2M $65.1M 79.0% 55.1% -$22.9M -$51.7M
FY 2023 $138.9M $12.0M — — -$18.7M -$32.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIBN // BETA —
BBNX // BETA —